DGYGX
Price
$35.46
Change
-$1.54 (-4.16%)
Updated
Apr 3 closing price
Net Assets
2.01B
GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

DGYGX vs GFACX

Header iconDGYGX vs GFACX Comparison
Open Charts DGYGX vs GFACXBanner chart's image
BNY Mellon Appreciation Y
Price$35.46
Change-$1.54 (-4.16%)
VolumeN/A
Net Assets2.01B
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
DGYGX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DGYGX vs. GFACX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGYGX is a Buy and GFACX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. DGYGX (2.01B). DGYGX pays higher dividends than GFACX: DGYGX (0.61) vs GFACX (0.00). DGYGX was incepted earlier than GFACX: DGYGX (12 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than DGYGX (0.59). GFACX is a more actively managed with annual turnover of: 25.00 vs. DGYGX (12.56). GFACX has a lower initial minimum investment than DGYGX: GFACX (250) vs DGYGX (1000000). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. DGYGX (-11.14). GFACX return over 5 years is better than : 59.73 vs. DGYGX (42.35).
DGYGXGFACXDGYGX / GFACX
Total Expense Ratio0.591.3643%
Annual Report Gross Expense Ratio0.591.3643%
Fund Existence12 years24 years-
Gain YTD-4.775-5.00395%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.01B280B1%
Annual Yield % from dividends0.610.00-
Returns for 1 year-11.14-1.75636%
Returns for 3 years-15.450.63-2,448%
Returns for 5 years42.3559.7371%
Returns for 10 years-27.3844.46-62%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences